Damora Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Damora Therapeutics, Inc.GLTOSep 28

   Jennifer Jarrett, insider filing for GLTO

   Jennifer Jarrett, reporting

2. ROUTINE4Damora Therapeutics, Inc.GLTOAug 13

   2 insider filings

   Andrew Cheng, insider filing for GLTO

   Show all 2

   • 4Insider filing for GLTOAug 13
   • 3New insider at GLTOAug 13

   Andrew Cheng, reporting

3. ROUTINEEFFECTDamora Therapeutics, Inc.GLTOAug 13

   Registration declared effective

4. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

   S-8 POS filing

5. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

   S-8 POS filing

6. ROUTINEPOSASRDamora Therapeutics, Inc.GLTOAug 10

   POSASR filing

7. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

   S-8 POS filing

8. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

   S-8 POS filing

9. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

   S-8 POS filing

10. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

    S-8 POS filing

11. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

    S-8 POS filing

12. ROUTINES-8 POSDamora Therapeutics, Inc.GLTOAug 10

    S-8 POS filing

13. ROUTINEPOS AMDamora Therapeutics, Inc.GLTOAug 10

    POS AM filing

14. ROUTINE8-A12B/ADamora Therapeutics, Inc.GLTOAug 10

    8-A12B filing (amended)

15. NOTABLE10-QDamora Therapeutics, Inc.GLTOAug 10

    Quarterly report

16. ROUTINE144Damora Therapeutics, Inc.GLTOAug 6

    Lori Firmani, planned sale of GLTO shares

    Lori Firmani, reporting

17. ROUTINESCHEDULE 13GDamora Therapeutics, Inc.GLTOJul 28

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

18. ROUTINE8-KDamora Therapeutics, Inc.GLTOJul 20

    Current report

19. ROUTINE4Damora Therapeutics, Inc.GLTOJul 7

    Garrett Winslow, insider filing for GLTO

    Garrett Winslow, reporting

20. ROUTINE144Damora Therapeutics, Inc.GLTOJun 22

    Lori Firmani, planned sale of GLTO shares

    Lori Firmani, reporting

21. ROUTINE8-KDamora Therapeutics, Inc.GLTOJun 17

    Current report

22. ROUTINESCHEDULE 13G/ADamora Therapeutics, Inc.GLTOMay 15

    2 13G filings

    Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15

    Point72 Asset Management, L.P., filed by

23. ROUTINESCHEDULE 13GDamora Therapeutics, Inc.GLTOMay 15

    Ownership stake disclosure by Avoro Capital Advisors LLC

    Avoro Capital Advisors LLC, filed by

24. NOTABLE10-QDamora Therapeutics, Inc.GLTOMay 12

    Quarterly report

25. ROUTINE3Damora Therapeutics, Inc.GLTOMay 8

    Brian Burkavage, new insider at GLTO

    Brian Burkavage, reporting

26. ROUTINE8-KDamora Therapeutics, Inc.GLTOMay 4

    Current report

27. ROUTINEARSDamora Therapeutics, Inc.GLTOMay 1

    Annual report to shareholders

28. ROUTINEDEF 14ADamora Therapeutics, Inc.GLTOApr 29

    Proxy statement

29. ROUTINEDEFA14ADamora Therapeutics, Inc.GLTOApr 29

    Additional proxy materials

30. ROUTINESCHEDULE 13G/ADamora Therapeutics, Inc.GLTOApr 23

    2 13G filings

    Ownership stake disclosure by Paramora Holding LLC (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)Apr 23
    • SCHEDULE 13G/AOwnership stake disclosure (amended)Apr 23

    Paramora Holding LLC, filed by

31. ROUTINE8-KDamora Therapeutics, Inc.GLTOApr 20

    Current report

32. ROUTINE4Damora Therapeutics, Inc.GLTOApr 1

    2 insider filings

    Jennifer Jarrett, insider filing for GLTO

    Show all 2

    • 4Insider filing for GLTOApr 1
    • 3New insider at GLTOApr 1

    Jennifer Jarrett, reporting

33. ROUTINE4Damora Therapeutics, Inc.GLTOMar 25

    8 insider filings

    Garrett Winslow, insider filing for GLTO

    Show all 8

    • 4Insider filing for GLTOMar 25
    • 4Insider filing for GLTOMar 25
    • 4Insider filing for GLTOMar 25
    • 4Insider filing for GLTOMar 25
    • 4Insider filing for GLTOMar 25
    • 4Insider filing for GLTOMar 25
    • 3New insider at GLTOMar 25
    • 3New insider at GLTOMar 25

    Garrett Winslow, reporting

34. ROUTINE8-KDamora Therapeutics, Inc.GLTOMar 23

    Current report

35. ROUTINES-8Damora Therapeutics, Inc.GLTOMar 20

    Employee stock plan registration

36. NOTABLE10-KDamora Therapeutics, Inc.GLTOMar 19

    Annual report

37. ROUTINE8-KGalecto, Inc.GLTOMar 10

    Current report

38. ROUTINESCHEDULE 13G/AGalecto, Inc.GLTOMar 6

    Ownership stake disclosure by Ikarian Capital, LLC (amended)

    Ikarian Capital, LLC, filed by

39. ROUTINESCHEDULE 13GGalecto, Inc.GLTOFeb 17

    Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P.

    Venrock Healthcare Capital Partners III, L.P., filed by

Older filings on EDGAR